Lipid nanoparticle，LNP-RNA
FRx LNP
FRx LNP
FRx LNP is capable of efficiently carrying various nucleic acid drugs (mRNA, siRNA, miRNA, etc.), achieving a high encapsulation efficiency of over 90%, and enhancing nucleic acid stability, allowing for precise delivery and expression in cells
Applicable dosage form and product application types
Applicable dosage form: Injection
Product application types
- Nucleic acid drugs
FRx LNP-compatible drug properties/ ImprovePoints
- Large molecule nucleic acid drug/
Low encapsulated efficiency - Single-stranded RNA/Poor stability
Advantages
- Attainable encapsulation efficiency of 90% or higher
- Enhanced stability of nucleic acid drugs for precise delivery
- Easy scaling-up of the manufacturing process with consistent quality
Technical implementation example
Over 90% encapsulation efficiency and precise control of particle size, enabling successful expression in cells
Partnership
FormuRx's core team is well-versed in the key physicochemical properties and delivery technologies of formulation development in the commercialization process. With a focus on lipid-based drug delivery system as a unique delivery technology, we offer collaborative development or services for the benefit of patients and the industry.
Phone
+886-2-2367-6828
service@formurx.com
Location
Rm. B406, No. 18, Siyuan St., Zhongzheng Dist., Taipei City 100,Taiwan (R.O.C.)